Reduction of plasma sCD40L and stimulated MIP-1-alpha production by in vivo beta-adrenergic stimulation

Neuroimmunomodulation. 2007;14(5):266-71. doi: 10.1159/000113433. Epub 2008 Jan 16.

Abstract

Background: beta-Adrenergic receptor stimulation appears to have contrasting effects on inflammatory processes.

Methods: In 25 healthy volunteers we examined the effects of a 20-min isoproterenol infusion (20 ng/kg/min) on systemic and peripheral blood mononuclear cell (PBMC) production of LPS-stimulated inflammatory mediators.

Results: Plasma soluble CD40 ligand and stimulated MIP-1alpha production were both reduced (p < or = 0.05) by systemic beta-adrenergic stimulation. Stimulated TNF-alpha production was reduced (p < 0.03) but plasma TNF-alpha was unchanged. In contrast, plasma IL-6 was elevated (p < 0.05) while stimulated IL-6 was unchanged, indicating the main source may not be PBMCs.

Conclusions: beta-Adrenergic receptor activation leads to a reduction in markers of the early inflammation cascade. Our findings also suggest that adipose tissue is a contributing source of beta-adrenergically stimulated increases in circulating IL-6. Since beta-adrenergic agonists and antagonists are commonly used in the treatment of disease, it is important that we clearly elucidate and contrast their systemic versus cell-specific effects.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adipose Tissue / drug effects
  • Adipose Tissue / immunology
  • Adipose Tissue / metabolism
  • Adrenergic beta-Agonists / pharmacology*
  • Adult
  • Biomarkers / analysis
  • Biomarkers / blood
  • CD40 Ligand / blood
  • CD40 Ligand / drug effects*
  • CD40 Ligand / immunology
  • Chemokine CCL3 / drug effects*
  • Chemokine CCL3 / immunology
  • Chemokine CCL3 / metabolism
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Female
  • Humans
  • Inflammation / blood
  • Inflammation / drug therapy*
  • Inflammation / immunology
  • Interleukin-6 / blood
  • Isoproterenol / pharmacology
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / metabolism
  • Lipopolysaccharides
  • Male
  • Middle Aged
  • Neuroimmunomodulation / drug effects
  • Neuroimmunomodulation / immunology
  • Receptors, Adrenergic, beta / drug effects*
  • Receptors, Adrenergic, beta / metabolism
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / drug effects

Substances

  • Adrenergic beta-Agonists
  • Biomarkers
  • CCL3 protein, human
  • Chemokine CCL3
  • Interleukin-6
  • Lipopolysaccharides
  • Receptors, Adrenergic, beta
  • Tumor Necrosis Factor-alpha
  • CD40 Ligand
  • Isoproterenol